A pilot open clinical trial of intravenous immunoglobulin in childhood autism

Journal of Autism and Developmental Disorders

Volumn 29, Issue 2, 1999, Pages 157-160

  DelGiudice Asch, Gina ^a   Simon, Lorraine ^a   Schmeidler, James ^a   Cunningham Rundles, Charlotte ^a   Hollander, Eric ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; AUTISM; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCORING SYSTEM; SENSORIMOTOR FUNCTION; SOCIAL INTERACTION; TREATMENT OUTCOME; CHILD; IMMUNOLOGY; PILOT STUDY; PSYCHOLOGICAL RATING SCALE; STATISTICAL ANALYSIS;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0033110041     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023096728131     Document Type: Article

References (27)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, (4th ed.). Washington, DC: Author.
2. DelGiuidce-Asch, G. & Hollander, E. (1997). Altered immune function in autism. CNS Spectrums: International Journal of Neuropsychiatric Medicine, 2, 61-68.
3. Dwyer, J. M. (1992). Manipulating the immune system with immunoglobulin. New England Journal of Medicine, 326, 4104-4109.
4. Edan, G. & Landgraf, F. (1994). Experience with intravenous immunoglobulin in myasthenia gravis: a review. Journal of Neurology, Neurosurgery, and Psychiatry, 57, S55-56.
5. Freeman, B. J. Ritvo, E. R., Yokota, A., & Ritvo A. (1986). A scale for rating symptoms of patients with the syndrome of autism in real life settings. Journal of the American Academy of Child Psychiatry, 25, 130-136.
6. Goodman, W., Price, L., Ramussen, S., & Mazure, C. (1989a). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Part 1. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
7. Goodman, W., Price, L., Ramussen, S., & Mazure, C. (1989b). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Part 2. Validity. Archives of General Psychiatry, 46, 1012-1016.
8. Gupta, S., Aggarwal, S., & Heads, C. (1996). Brief report: Dysregulated immune system in children with autism; beneficial effects of intravenous immune globulin on autistic characteristics. Journal of J Autism and Developmental Disorders, 26, 439-452.
9. Guy, W. (1976). E.C.D.E.U. Assessment manual for psychopharmacology (DHEW Publication, pp. 76-338). Washington DC: U.S. Government Printing Office.
10. Kanner, L. (1943). Autistic disturbances of affective contact. Nervous Child, 2, 217-250.
11. Le Couteur, A., Rutter, M., Lord, C., & Rios, P. (1989). Autism Diagnostic Interview: A semistructured interview for parents and caregivers of autistic persons. Journal of Autism and Developmental Disorders, 19, 363-387.
12. Plioplys, A. V., Greaves, A., & Yoshida W.(1989). Anti-CNS antibodies in childhood neurologic diseases. Neuropaediatrics, 20, 92-102.
13. Rapoport, J., Elkins, R., Mikkelsen, E. (1980). Clinical controlled trial of clomipramine in adolescents with obsessive compulsive disorder. Psychopharmacology Bulletin, 16(3), 61-63.
14. Singh, V. K., Fudenberg, H. H., Emerson, D., & Coleman, M. (1988). Immunodiagnosis and immunotheraphy in autistic children. Annals of the New York Academy of Science, 540, 602-604.
15. Singh, V. K., Warren, R. P., Odell, J. D., & P. Cole (1991). Changes of soluble IL-2, IL-2R, T8 antigen and IL-1 in the serum of autistic children. Clinical Immunology and Immunopathology, 61, 448-455.
16. Singh, V. K., Warren, R. P., Odell J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior and Immunology, 7, 97-103.
17. Todd, R. D., & Ciaranello, R. D. (1985). Demonstration of inter-and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proceedings of the National Academy of Science U.S., 82, 612-616.
18. Vajsar, J., Sloane, A., Wood, E., & Murphy, E. G. (1994). Plasmaphaersis versus Intravenous immunoglobulin in childhood Guillan-Barre syndrome. Archives of Pediatric and Adolescent Medicine, 148, 1210-1212.
19. van Engelen, B. G., Renier, W. O., Weemas, C. M., Gabreels, F. J., & Meinardi, H. (1994). Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Research, 19, 181-190.
20. Van Schaik, I. L., Vermeulen, M., van Dorn, P. A., & Brand A.(1994). Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIG). Journal of Neuroimmunology, 54, 109-115.
21. Warren, R. P., Foster, A., Margaretten, N. C., & Pace, N. C. (1986). Immune abnormalities in patients with autism. Journal of Autism and Developmental Disorders, 16, 189-197.
22. Warren, R. P., Foster, A., & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333-335.
23. Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., & White, E. (1991). Increased frequency of the null allele at the complements C4B locus in autism. Clinical and Experimental Immunology, 83, 438-440.
24. Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., DeWitt, C. W., & McCullough, M. (1992). Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunology, 36, 203-207.
25. Warren, R. P., Yonk, L. J., Burger, R. A., et al. (1990). Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest, 19, 245-251.
26. Yonk, L. J., Warren, R. P., Burger, R. A., et al. (1990). CD4 and helper T cell depression in autism. Immunology Letters, 25, 341-346.
27. Zimmerman, A., Frye, V. H., & Potter, N. T. (1993). Immunological aspects of autism. International Journal of Pediatrics, 8, 199-204.